Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 5.24B | 5.72B | 5.77B | 5.73B | 5.64B |
| Total Depreciation and Amortization | 3.08B | 3.04B | 3.02B | 2.99B | 2.97B |
| Total Amortization of Deferred Charges | 35.00M | 33.00M | 31.00M | 31.00M | 29.00M |
| Total Other Non-Cash Items | 1.53B | 802.00M | 830.00M | 1.10B | 1.03B |
| Change in Net Operating Assets | -457.00M | -305.00M | 175.00M | -875.00M | -1.15B |
| Cash from Operations | 9.43B | 9.28B | 9.83B | 8.98B | 8.52B |
| Capital Expenditure | -4.74B | -4.91B | -4.89B | -4.73B | -4.40B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -635.00M | -329.00M | -232.00M | -337.00M | -224.00M |
| Divestitures | 193.00M | 768.00M | 1.39B | 1.39B | 1.24B |
| Other Investing Activities | -131.00M | -44.00M | -12.00M | -15.00M | -7.00M |
| Cash from Investing | -5.32B | -4.51B | -3.75B | -3.70B | -3.39B |
| Total Debt Issued | 3.22B | 3.36B | 2.44B | 1.39B | 6.12B |
| Total Debt Repaid | -1.93B | -1.94B | -2.59B | -534.00M | -2.83B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.81B | -4.42B | -3.98B | -5.75B | -7.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -661.00M | -657.00M | -655.00M | -651.00M | -653.00M |
| Other Financing Activities | -917.00M | -1.24B | -1.30B | -1.27B | -1.29B |
| Cash from Financing | -4.09B | -4.89B | -6.08B | -6.81B | -5.66B |
| Foreign Exchange rate Adjustments | 7.00M | 14.00M | 4.00M | -8.00M | -20.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.00M | -108.00M | 4.00M | -1.53B | -543.00M |